Jon Skinner
Chief Financial OfficerMr. Jon Skinner is Chief Financial Officer of Pulse Biosciences, Inc. from February 3, 2025. Mr. Skinner is an accomplished financial leader with experience across the healthcare sector. He most recently served as Vice President, FP&A and Investor Relations at Copeland, a private equity backed industrial company. Prior to this role, Mr. Skinner was Vice President, Finance and Corporate Development at Imperative Care. There, he spearheaded M&A, strategy, partnerships and sales operations along with providing financial and strategic support for all development stage business units. While at Imperative Care, he also served as the interim CFO of Kandu Health during its spin-out and fundraising process. Prior to his time at Imperative Care, Mr. Skinner served as Vice President, Finance Interventional Urology at Teleflex. There he led accounting, FP&A, customer service and sales operations for the Interventional Urology Business Unit, following his role as Senior Director, Corporate Development, where he helped close 25 M&A transactions. Prior to Teleflex, Mr. Skinner spent time at Axalta Coating Systems working on its carve-out and IPO and at Duff & Phelps (now Kroll) in the Valuation Advisory Group. Mr. Skinner holds a Bachelor of Science and a Master of Business Administration from The Ohio State University.
Positions
- Company NamePulse Biosciences, Inc.Stock CodePLSEPositionChief Financial OfficerColleagues
- PAPaul Arthur LaViolettePresident, CEO & Co-Chairman of the Board
- RWRobert W. DugganIndependent Co-Chairman
- DRDarrin R. UeckerCTO & Director
- LTLiane TeplitskyChief Operating Officer
- STSteven T. WeberVP of Accounting, Principal Accounting Officer & Global Corporate Controller
- MSManmeet Singh SoniLead Independent Director
- MZMahkam ZanganehIndependent Director
